Live Breaking News & Updates on Martyj Duvall

Stay updated with breaking news from Martyj duvall. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Angiex Strengthens its Leadership Team with the Appointment of Marty J. Duvall as Chief Executive Officer

/PRNewswire/ Angiex, developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, has appointed Marty J. Duvall as chief. ....

Martyj Duvall , Paul Jaminet , Angiex Founder , President Paul Jaminet , Orbimed Advisors , Angiex Inc ,

Oncopeptides publishes year-end report 2021

/PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on the development of therapies for difficult-to-treat hematological. ....

United States , United Kingdom , Martyj Duvall , Anders Martin , Annika Muskantor , Rolf Gulliksen , Linda Holmstr , Jakob Lindberg , American Society Of Hematology Meeting , Global Head Of Corporate Communications , Nasdaq Stockholm , Annual American Society , Hematology Meeting , Lancet Haematology , Oncopeptide Leadership , Abuse Regulation , Securities Markets , Global Head , Corporate Communications , Investor Relations , Mid Cap , Oncopeptides Ab ,

Oncopeptides publishes year-end report 2021

/PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on the development of therapies for difficult-to-treat hematological. ....

United States , United Kingdom , Martyj Duvall , Anders Martin , Annika Muskantor , Rolf Gulliksen , Linda Holmstr , Jakob Lindberg , American Society Of Hematology Meeting , Global Head Of Corporate Communications , Nasdaq Stockholm , Annual American Society , Hematology Meeting , Lancet Haematology , Oncopeptide Leadership , Abuse Regulation , Securities Markets , Global Head , Corporate Communications , Investor Relations , Mid Cap , Oncopeptides Ab ,

Oncopeptides AB: Oncopeptides publishes year-end report 2021

STOCKHOLM, Feb. 17, 2022 /PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on the development of therapies for difficult-to-treat hematological diseases ....

United States , United Kingdom , Martyj Duvall , Anders Martin , Annika Muskantor , Rolf Gulliksen , Linda Holmstr , Jakob Lindberg , American Society Of Hematology Meeting , Global Head Of Corporate Communications , Nasdaq Stockholm , Annual American Society , Hematology Meeting , Lancet Haematology , Oncopeptide Leadership , Abuse Regulation , Securities Markets , Global Head , Corporate Communications , Investor Relations , Mid Cap ,

Oncopeptides AB: Oncopeptides publishes Q3 2021 report

Back to the future STOCKHOLM, Nov. 24, 2021 /PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat ....

United Kingdom , Martyj Duvall , Anders Martin , Annika Muskantor , Rolf Gulliksen , Linda Holmstr , Jakob Lindberg , Global Head Of Corporate Communications , Nasdaq Stockholm , Oncopeptide Leadership , Global Head , Corporate Communications , Investor Relations , Abuse Regulation , Securities Markets , Corporate Headquarters , Mid Cap ,